|
|
 |
Home > R&D > Field of study |
|
|
 |
Biological medicines
are studied and developed by using development of the
technology for manufacture of genes, highly productive
fermentation process, and protein engineering technology
for the core basis technologies.
Further, the company performs active cooperative studies
among industry, academy, and research institutes with
Biotechnology Research Institute, Korea Science and Technology
Institute, Seoul National University, Catholic Medical
School, etc. and puts efforts into development of medicines
such as proteins, peptides, and antibiotics, etc. through
active participation in the government-donated research
and development projects of Ministry of Science and Technology,
Ministry of Health and Welfare, Ministry of Commerce,
Industry, and Energy, etc.
|
| |
<Research projects on progress >
- Gene re-combination proteins for treatment
of osteoporosis
- Gene re-combination anti-coagulant proteins
- Antibiotics using fermentation process of microorganisms
- Peptide antibiotics
|
 |
The priority of
the company is to promote development of competitive high-quality
raw material medicines through creation of new processes
based on accumulated know-how for the aim of development
of high value added raw materials using synthesis of new
raw materials and chirotechnology. Also, in combination
with the above, the company puts efforts into maximization
of efficiency for synthetic processes based on operation
of KG-lab, internal analysis system, etc.
|
| |
<Research projects on progress >
- Cilastatin sodium and intermediates
- Raw material for treatment of dementia
- New treatment agents of wound: Wound treatment agents
of which candidate materials are Asiaticoside derivatives
- Analgesics in the alkaloid group: New analgesics in
the oripavine group
|
|
|
|
